Researchers used epigenetic modulators to reduce the damage done by stress to neuroplasticity. Findings reveal acute intervention in epigenetic mechanisms produced antidepressant effects more rapidly than conventional medications.
Cannabidiol (CBD) can inhibit aggressiveness associated with social isolation, a new mouse model study reveals.
A study using rat models of depression reveals a single dose of the cannabis extract CBD can help to reduce symptoms of depression for up to one week. Researchers say cannabidiol appears to activate mechanisms that help repair neural circuitry in the prefrontal cortex and hippocampus, which get damaged as a result of depression.
Using a green filter help to increase reading speed for children with dyslexia, researchers report.
Researchers found a significant link between olfaction and visual sensory processing, reporting specific smells influence the identification of facial emotions, and facial expressions influence the emotional response to smell.
A new study reveals how the COVID-19 pandemic changed the perception of time for many people. Researchers say people felt time passed more slowly during COVID lockdowns. This "time expansion" was associated with increased feelings of loneliness and a lack of positive experience during the early parts of the COVID pandemic.
Lack of oxygen to the fetus during pregnancy as a result of pre-eclampsia may increase the risk for schizophrenia, a new study reports.
Study finds a link between early-life poverty and child adversity and an increased risk of developing externalizing disorders during adolescence and young adulthood, especially in females.
Focusing on genes associated with psychiatric and neurological disorders, and drugs approved for use in other diseases, a new AI system can increase the effectiveness of drug repurposing.
Researchers say our dreams are reflecting fears and anxiety associated with the COVID-19 pandemic.
Melatonin produced in the lungs acts as a barrier defense against SARS-CoV-2, the virus that causes COVID-19, by blocking the expression of genes that encode proteins in cells acting as viral entry points.
Brain dysfunction noted in schizophrenia patients may be a result of impaired expression of a protein complex associated with protein synthesis, researchers report.
